United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
NEW YORK, May 01, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas, Tyler Division on behalf of investors who purchased Adeptus Health Inc. ("Adeptus Health Inc.") (NYSE:ADPT) securities between April 29, 2016 and March 1, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra-sa/adeptus-health-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) Adeptus had material weaknesses in its internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures; and (2) as a result, defendants’ statements about Adeptus’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Adeptus Health Inc. you have until May 9, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/adeptus-health-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
